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We present a 74-year-old patient who under-
went aortic valve replacement with a porcine
bioprosthesis (St Jude Medical Epic 23 mm)
because of severe aortic stenosis. On a routine
visit 1-year postoperatively, the patient reported
mild symptoms of angina (CCS 2). Doppler
echocardiography demonstrated a mean gradi-
ent of 62 mmHg. Transoesophageal echocardi-
ography (TOE) is often inconclusive because of
shadowing of the bioprosthesis ring, and there-
fore, was not performed. Contrast-enhanced
ECG-gated computer tomography (ECG-gated
CT) showed substantial thickening of the
bioprosthetic leaflets (Supplementary material
online, Video S1; Panel A). On the basis of the
assessment of an obstructive bioprosthetic
valve thrombosis, the patient was started on
oral anticoagulation (INR 2.5–3.0). Six months
later, he was free of angina, on echocardiography,
the mean gradient had decreased to 24 mmHg,
and a repeat ECG-gated CT demonstrated
resolution of leaflet thickening (Supplementary
material online, Video S1; Panel B).
The diagnostic work-up of a high transvalvular
Doppler gradient in a bioprosthetic valve is chal-
lenging, since fluoroscopy is incapable of visualiz-
ing bioprosthetic leaflets and echocardiography
(including TEE) is often of limited value
because of shadowing. In contrast, ECG-gated
CT has the potential to visualize bioprosthetic
structures including leaflets and, therefore, may
differentiate thrombosis and pannus from
patient prosthesis mismatch. Anticoagulation
for obstructive thrombosis of bioprosthetic
aortic valves in clinically stable patients appears
safe, and timely use of ECG-gated CT may
obviate the need for further diagnostic proce-
dures and repeat surgery in this subset of patients.
Supplementary material is available at
European Heart Journal online.
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